1. Etiological factors in the development of the disease
When discussing the etiology of aplastic anemia, it is crucial to understand that a variety of agents can trigger the pathological process. Ultimately, all of them lead to the same result—massive damage and depletion of bone marrow cellular elements.
In clinical practice, several main groups of etiological factors are traditionally distinguished, which every physician should know:
- Idiopathic causes. Strikingly, in 50% of diagnosed aplastic anemia cases, it is completely impossible to reliably establish the primary cause of the disease. In such situations, the pathology is considered idiopathic, with no obvious triggering factors present.
- Physical factors. The main and most aggressive representative of this group is ionizing radiation, which has a direct destructive effect on progenitor cells in the bone marrow.
- Chemical factors. A classic example of severe chemical toxic effects on the hematopoietic system is prolonged or acute contact with benzene.
- Infectious factors. It has been proven that certain viral agents are capable of triggering bone marrow suppression. First and foremost, hepatitis virus belongs to such triggers.
- Iatrogenic (drug-induced) factors. This is an extensive group of medications whose use carries a risk of myelotoxicity. The list of hazardous drugs includes antibiotics (specifically, chloramphenicol, also known as levomycetin), nonsteroidal anti-inflammatory drugs (such as phenylbutazone or butadione), gold preparations, various cytostatics, and the H2-receptor antagonist cimetidine.
2. Clinical and laboratory presentation: "empty" bone marrow syndrome
The entire clinical picture of this disease directly depends on the degree of depression of specific hematopoietic lineages. The bone marrow becomes depleted of cellular elements—this condition is referred to in hematology as "empty" bone marrow syndrome.
The manifestations of the disease are grouped into three major syndromes, each corresponding to a deficiency of specific peripheral blood cells:
- Anemic syndrome (a consequence of suppressed erythropoiesis). It develops due to a critical decrease in red blood cell production. Blood analysis shows a significant drop in red blood cell levels. A key differential sign to pay attention to is the complete absence of reticulocytosis. This indicates the hyporegenerative nature of the anemia (the bone marrow is unable to generate new young cells in response to the deficiency).
- Hemorrhagic syndrome (a consequence of suppressed thrombocytopoiesis). Platelet deficiency naturally leads to disorders in the hemostatic system. Clinically, this manifests as pronounced bleeding and the development of thrombocytopenic purpura. The laboratory criterion for this syndrome is a sharp decrease in the platelet level, which often drops below the critical mark of $30 \times 10^9$/L.
- Infectious complications syndrome (a consequence of suppressed granulocytopoiesis). A drop in leukocyte count (specifically, the development of severe neutropenia) leaves the body without adequate immune defense. Patients demonstrate a marked predisposition to various infections, a typical and dangerous manifestation of which is severe tonsillitis. In laboratory tests for this syndrome, the leukocyte count often turns out to be below $2 \times 10^9$/L.
3. Management tactics for aplastic anemia
The approach to treating patients with aplastic anemia requires a comprehensive strategy and depends on the severity of hematopoietic lineage suppression. The main areas of therapy are based on compensating for lost functions and attempting to restore normal bone marrow function.
- Replacement therapy. This type of treatment is necessary for the rapid relief of life-threatening conditions associated with profound cell deficiency. Regular packed red blood cell transfusions are used to correct severe anemia. In turn, to correct dangerous thrombocytopenia and prevent fatal hemorrhages, platelet transfusions are indicated.
- Drug therapy. A crucial component of conservative treatment is the use of glucocorticoids, which help stabilize the patient's condition.
- Radical treatment. In cases where severe forms of the disease are diagnosed, conservative measures are insufficient. The only radical method capable of completely curing the patient is bone marrow transplantation, which is performed in the presence of strict clinical indications.
Briefly: answers to topical questions
What infectious agents act as triggers for aplastic anemia?
Among infectious agents, the hepatitis virus is a trigger for aplastic anemia. In addition, viral infections are detected in the history of approximately 1 in 10 patients with this disease.
What does the bone marrow picture look like on puncture or trephine biopsy in aplastic anemia?
The bone marrow picture in aplastic anemia is characterized by "empty" bone marrow syndrome, meaning a low number of cellular elements.
- Bone marrow puncture reveals decreased cellularity and an absence of megakaryocytes.
- Trephine biopsy reveals bone marrow aplasia (predominance of adipose tissue). Hematopoietic tissue is replaced by fatty tissue, with only islands of myeloid (hematopoietic) tissue remaining.
What conservative treatment methods are used for aplastic anemia?
Conservative treatment of aplastic anemia includes replacement therapy and immunosuppressive drug therapy.
- Replacement therapy — transfusions of packed red blood cells and platelets.
- Drug therapy — administration of glucocorticoids.
- Protocol-based combined immunosuppressive therapy (IST) — use of drugs with pronounced immunosuppressive effects: antithymocyte globulin (ATG) and cyclosporine.
What diseases should aplastic anemia be differentiated from?
Aplastic anemia must be differentiated from the following diseases and conditions:
- Preleukemic conditions;
- Myelodysplastic syndrome (MDS);
- Myelophthisic anemia (occurring with tumor metastasis replacement of the bone marrow, myelofibrosis, granulomatous diseases);
- Vitamin B12-deficiency anemia;
- Hypersplenism.
The rule of three "NO"s for pancytopenia: NO red blood cells (and reticulocytes!), NO platelets, NO white blood cells = empty bone marrow.
Class and exam questions
What main laboratory sign distinguishes aplastic anemia from other types of anemia?
The key differential sign is the hyporegenerative nature of the anemia. It manifests as a complete absence of reticulocytosis against the background of a significant decrease in red blood cell levels.
Why do patients with this disease frequently develop severe tonsillitis?
The predisposition to infections (including tonsillitis) arises from the infectious complications syndrome, which is based on the suppression of granulocytopoiesis, leading to neutropenia and a drop in leukocyte levels below $2 \times 10^9$/L.
Which medications most frequently cause the iatrogenic form of the disease?
Iatrogenic factors include antibiotics (chloramphenicol/levomycetin), NSAIDs (phenylbutazone), gold preparations, cytostatics, and cimetidine.
What is the radical treatment method for severe forms?
In severe forms of aplastic anemia, the only radical treatment method indicated for the patient is bone marrow transplantation.
What else to study on this topic
- Mechanism of development of hyporegenerative anemia
- Differential diagnosis of the causes of pancytopenia
- Indications for bone marrow transplantation in severe forms
- Mechanism of action of glucocorticoids in aplastic anemia
- Isolated forms of hematopoietic lineage suppression
Master the entire topic in the "Propaedeutics" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Aplastic anemia" and 3,152 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 113 video lessons on the subject
Other topics in the "Blood System" section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.